SE9702772D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE9702772D0
SE9702772D0 SE9702772A SE9702772A SE9702772D0 SE 9702772 D0 SE9702772 D0 SE 9702772D0 SE 9702772 A SE9702772 A SE 9702772A SE 9702772 A SE9702772 A SE 9702772A SE 9702772 D0 SE9702772 D0 SE 9702772D0
Authority
SE
Sweden
Prior art keywords
pct
novel compounds
sec
date
pub
Prior art date
Application number
SE9702772A
Other languages
English (en)
Inventor
David Hardern
Brian Springthorpe
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9702772A priority Critical patent/SE9702772D0/sv
Publication of SE9702772D0 publication Critical patent/SE9702772D0/sv
Priority to IDW20000146A priority patent/ID24837A/id
Priority to SK1880-99A priority patent/SK188099A3/sk
Priority to IL13411298A priority patent/IL134112A0/xx
Priority to BR9811022-5A priority patent/BR9811022A/pt
Priority to EP98934106A priority patent/EP0996620B1/en
Priority to US09/155,562 priority patent/US6156756A/en
Priority to CN98809135A priority patent/CN1271359A/zh
Priority to AT98934106T priority patent/ATE216389T1/de
Priority to EEP200000042A priority patent/EE200000042A/xx
Priority to HU0100202A priority patent/HUP0100202A3/hu
Priority to AU83705/98A priority patent/AU8370598A/en
Priority to DE69804964T priority patent/DE69804964T2/de
Priority to KR1020007000651A priority patent/KR20010022082A/ko
Priority to JP2000504138A priority patent/JP2001510841A/ja
Priority to CA002296648A priority patent/CA2296648A1/en
Priority to PL98338518A priority patent/PL338518A1/xx
Priority to TR2000/00151T priority patent/TR200000151T2/xx
Priority to PCT/SE1998/001392 priority patent/WO1999005142A1/en
Priority to IS5351A priority patent/IS5351A/is
Priority to NO20000311A priority patent/NO20000311L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
SE9702772A 1997-07-22 1997-07-22 Novel compounds SE9702772D0 (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE9702772A SE9702772D0 (sv) 1997-07-22 1997-07-22 Novel compounds
IDW20000146A ID24837A (id) 1997-07-22 1997-07-24 Senyawa triazolo [4,5-d] pirimidina, penggunaan, komposisi dan proses pembuatannya
PCT/SE1998/001392 WO1999005142A1 (en) 1997-07-22 1998-07-15 Novel compounds
AT98934106T ATE216389T1 (de) 1997-07-22 1998-07-15 Neue verbindungen
AU83705/98A AU8370598A (en) 1997-07-22 1998-07-15 Novel compounds
BR9811022-5A BR9811022A (pt) 1997-07-22 1998-07-15 Composto, composição farmacêutica, e, processo para preparação de um composto
EP98934106A EP0996620B1 (en) 1997-07-22 1998-07-15 Novel compounds
US09/155,562 US6156756A (en) 1997-07-22 1998-07-15 Triazolo [4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation
CN98809135A CN1271359A (zh) 1997-07-22 1998-07-15 新的化合物
SK1880-99A SK188099A3 (en) 1997-07-22 1998-07-15 Triazolo[4,5-d]pyrimidine compounds, preparation thereof, pharmaceutical compositions containing them and their use
EEP200000042A EE200000042A (et) 1997-07-22 1998-07-15 Uued ühendid
HU0100202A HUP0100202A3 (en) 1997-07-22 1998-07-15 Novel triazolo[4,5-d]pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
IL13411298A IL134112A0 (en) 1997-07-22 1998-07-15 Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation
DE69804964T DE69804964T2 (de) 1997-07-22 1998-07-15 Neue verbindungen
KR1020007000651A KR20010022082A (ko) 1997-07-22 1998-07-15 신규 화합물
JP2000504138A JP2001510841A (ja) 1997-07-22 1998-07-15 新規な化合物
CA002296648A CA2296648A1 (en) 1997-07-22 1998-07-15 Novel compounds
PL98338518A PL338518A1 (en) 1997-07-22 1998-07-15 Novel compounds
TR2000/00151T TR200000151T2 (tr) 1997-07-22 1998-07-15 Yeni bileşimler.
IS5351A IS5351A (is) 1997-07-22 2000-01-19 Ný efnasambönd
NO20000311A NO20000311L (no) 1997-07-22 2000-01-21 Nye forbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702772A SE9702772D0 (sv) 1997-07-22 1997-07-22 Novel compounds

Publications (1)

Publication Number Publication Date
SE9702772D0 true SE9702772D0 (sv) 1997-07-22

Family

ID=20407803

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702772A SE9702772D0 (sv) 1997-07-22 1997-07-22 Novel compounds

Country Status (21)

Country Link
US (1) US6156756A (sv)
EP (1) EP0996620B1 (sv)
JP (1) JP2001510841A (sv)
KR (1) KR20010022082A (sv)
CN (1) CN1271359A (sv)
AT (1) ATE216389T1 (sv)
AU (1) AU8370598A (sv)
BR (1) BR9811022A (sv)
CA (1) CA2296648A1 (sv)
DE (1) DE69804964T2 (sv)
EE (1) EE200000042A (sv)
HU (1) HUP0100202A3 (sv)
ID (1) ID24837A (sv)
IL (1) IL134112A0 (sv)
IS (1) IS5351A (sv)
NO (1) NO20000311L (sv)
PL (1) PL338518A1 (sv)
SE (1) SE9702772D0 (sv)
SK (1) SK188099A3 (sv)
TR (1) TR200000151T2 (sv)
WO (1) WO1999005142A1 (sv)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
DE69905451T2 (de) * 1998-02-17 2003-11-20 Astrazeneca Uk Ltd Neue triazolo(4,5d) pyrimidinverbindungen
SE9802574D0 (sv) * 1998-07-17 1998-07-17 Astra Pharma Prod Novel compounds
TWI229674B (en) * 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
SE9904128D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
US6867199B2 (en) 2000-08-21 2005-03-15 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapeutic use
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
US7749981B2 (en) 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7368438B2 (en) 2003-10-21 2008-05-06 Inspire Pharmaceuticals, Inc. Non-nucleotide compositions and method for inhibiting platelet aggregation
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
US7566722B2 (en) * 2006-10-31 2009-07-28 Janssen Pharmaceutica, N.V. Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists
WO2008054796A2 (en) 2006-10-31 2008-05-08 Janssen Pharmaceutica, N.V. Triazolopyrimidine derivatives as adp p2y12 receptor antagonists
TWI496776B (zh) * 2007-11-15 2015-08-21 Astrazeneca Ab 製備(3aR,4S,6R,6aS)-6-胺基-2,2-二甲基四氫-3aH-環戊并[d][1,3]二氧雜環戊烯-4-醇之純非對映異構性之二苯甲醯-L-酒石酸鹽之方法
EP2361242B1 (en) 2008-10-17 2018-08-01 Oryzon Genomics, S.A. Oxidase inhibitors and their use
WO2010084160A1 (en) 2009-01-21 2010-07-29 Oryzon Genomics S.A. Phenylcyclopropylamine derivatives and their medical use
EP2459564B1 (en) 2009-07-27 2016-09-07 Auspex Pharmaceuticals, Inc. Cyclopropyl modulators of p2y12 receptor
MX338041B (es) 2009-09-25 2016-03-30 Oryzon Genomics Sa Inhibidores de demetilasa-1 especificos de lisina y su uso.
EP2486002B1 (en) 2009-10-09 2019-03-27 Oryzon Genomics, S.A. Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
CA2788072A1 (en) 2010-02-16 2011-08-25 Actavis Group Ptc Ehf Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
US9616058B2 (en) 2010-02-24 2017-04-11 Oryzon Genomics, S.A. Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use
US9186337B2 (en) 2010-02-24 2015-11-17 Oryzon Genomics S.A. Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae
KR101794020B1 (ko) 2010-04-19 2017-11-06 오리존 지노믹스 에스.에이. 라이신 특이적 디메틸라아제-1 억제제 및 이의 용도
US9181198B2 (en) 2010-07-29 2015-11-10 Oryzon Genomics S.A. Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
WO2012013727A1 (en) 2010-07-29 2012-02-02 Oryzon Genomics S.A. Cyclopropylamine derivatives useful as lsd1 inhibitors
WO2012045883A1 (en) 2010-10-08 2012-04-12 Oryzon Genomics S.A. Cyclopropylamine inhibitors of oxidases
WO2012063126A2 (en) 2010-11-09 2012-05-18 Actavis Group Ptc Ehf Improved processes for preparing pure (3ar,4s,6r,6as)-6-amino-2,2-dimethyltetrahdro-3ah-cyclopenta[d] [1,3]-dioxol-4-ol and its key starting material
WO2012072713A2 (en) 2010-11-30 2012-06-07 Oryzon Genomics, S.A. Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
MX2013007115A (es) 2010-12-20 2014-02-10 Actavis Group Ptc Ehf Procesos novedosos para preparar derivados de triazolo[4, 5 - d] pirimidina e intermediarios de los mismos.
EP2712315B1 (en) 2011-02-08 2021-11-24 Oryzon Genomics, S.A. Lysine demethylase inhibitors for myeloproliferative disorders
CZ2011229A3 (cs) 2011-04-19 2012-08-15 Zentiva, K.S. Opticky aktivní soli (3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyklopenta-[d][1,3]dioxol-4-olu a zpusob jejich prípravy
BR112013028936B1 (pt) * 2011-05-13 2021-10-19 Astrazeneca Ab Processo para a preparação de benzil [(3as,4r,6s,6ar)-6-hidróxi-2,2-dimetiltetra-hidro- 3ahciclopenta[d]dioxol]-4-il]carbamato e compostos intermediários no processo
US20140206867A1 (en) 2011-06-15 2014-07-24 Actavis Group Ptc Ehf Process for Preparing Cyclopentylamine Derivatives and Intermediates Thereof
CN102924457A (zh) * 2011-08-12 2013-02-13 上海恒瑞医药有限公司 三唑并嘧啶类衍生物、其制备方法及其用途
RS58475B1 (sr) 2011-10-20 2019-04-30 Oryzon Genomics Sa Jedinjenja (hetero)aril ciklopropilamina kao lsd1 inhibitori
CN107266345B (zh) 2011-10-20 2021-08-17 奥瑞泽恩基因组学股份有限公司 作为lsd1抑制剂的(杂)芳基环丙胺化合物
CN102659691B (zh) * 2012-05-23 2014-04-02 山东诚创医药技术开发有限公司 一种4,6-二氯-5-氨基-2-丙硫基嘧啶的制备方法
CA3012242C (en) 2012-12-21 2021-11-02 Gilead Sciences, Inc. Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
WO2014206187A1 (zh) 2013-06-24 2014-12-31 苏州明锐医药科技有限公司 替卡格雷及其中间体的制备方法
NO2865735T3 (sv) 2013-07-12 2018-07-21
JP6411491B2 (ja) 2013-07-12 2018-10-24 ギリアード サイエンシス インコーポレーテッド 多環式カルバモイルピリドン化合物およびｈｉｖ感染症を処置するためのその使用
WO2015162630A1 (en) 2014-04-25 2015-10-29 Anlon Chemical Research Organization Novel processes for preparing triazolo [4,5-d]- pyrimidines, including ticagrelor, vianew intermediates and new route of synthesis.
TWI744723B (zh) 2014-06-20 2021-11-01 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
NO2717902T3 (sv) 2014-06-20 2018-06-23
WO2018183965A1 (en) * 2017-03-30 2018-10-04 Corvus Pharmaceuticals, Inc. Processes for making triazolo[4,5d] pyramidine derivatives and intermediates thereof
WO2019016111A1 (en) * 2017-07-18 2019-01-24 Lonza Ltd PROCESS FOR THE PREPARATION OF CHLORINATED S-PROPYLTHIOBARBITURIC ACID
WO2020068583A1 (en) * 2018-09-27 2020-04-02 Corvus Pharmaceuticals, Inc. Processes for making triazolo [4,5d] pyramidine derivatives and intermediates thereof
CN111116592A (zh) * 2019-11-27 2020-05-08 杭州沧海帆医药科技有限公司 嘧啶并三氮唑类化合物及其医药用途
CN115710275B (zh) * 2022-11-21 2024-02-02 河南中医药大学 一种嘧啶-tcp类化合物、制备方法和医药用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
EP0840740B1 (en) * 1995-07-11 2002-05-02 AstraZeneca AB New inhibitors of platelet aggregation
WO1998028300A1 (en) * 1996-12-20 1998-07-02 Astra Pharmaceuticals Ltd. Triazolo[4,5-d]pyrimidinyl derivatives and their use as medicaments

Also Published As

Publication number Publication date
ATE216389T1 (de) 2002-05-15
NO20000311D0 (no) 2000-01-21
PL338518A1 (en) 2000-11-06
WO1999005142A1 (en) 1999-02-04
DE69804964D1 (de) 2002-05-23
SK188099A3 (en) 2000-08-14
HUP0100202A3 (en) 2001-10-29
TR200000151T2 (tr) 2000-09-21
AU8370598A (en) 1999-02-16
CA2296648A1 (en) 1999-02-04
EE200000042A (et) 2000-10-16
EP0996620B1 (en) 2002-04-17
CN1271359A (zh) 2000-10-25
ID24837A (id) 2000-08-24
DE69804964T2 (de) 2002-11-07
EP0996620A1 (en) 2000-05-03
IS5351A (is) 2000-01-19
HUP0100202A2 (hu) 2001-08-28
BR9811022A (pt) 2000-09-12
JP2001510841A (ja) 2001-08-07
KR20010022082A (ko) 2001-03-15
US6156756A (en) 2000-12-05
NO20000311L (no) 2000-03-21
IL134112A0 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
SE9702772D0 (sv) Novel compounds
UA66801C2 (uk) Триазоло[4,5-d]піримідинові сполуки, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі та спосіб лікування порушень агрегації тромбоцитів
MY121867A (en) Novel triazolo(4,5-d)pyrimidine compounds.
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
SE9701398D0 (sv) Novel compounds
IL133825A0 (en) Substituted 6-phenylphenanthridines, medicaments containing same and use thereof
EE9900315A (et) Pürrolo[3,4-d]pürimidinooni derivaadid ja nende kasutamine ravimitena
TR200000152T2 (tr) Yeni bileşikler.
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
HK1056361A1 (en) Novel compounds